Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael S Silverman

Showing results (11-20 of 37) with videos related to

Pageof 4
Sort By:
Transplant Infectious Disease : an Official Journal of the Transplantation Society|May 29, 2023
The effect of late-onset CMV infection on the outcome of renal allograft considering initial graft functionMohammadreza R Shahmirzadi, Lakshman Gunaratnam, Anthony M Jevnikar, et al.
Frontiers in Medicine|August 28, 2020
Treating From the Inside Out: Relevance of Fecal Microbiota Transplantation to Counteract Gut Damage in GVHD and HIV InfectionJing Ouyang, Stéphane Isnard, John Lin, et al.
JAMA Network Open|December 29, 2021
Incidence and Outcomes Associated With Clostridioides difficile Infection in Solid Organ Transplant RecipientsSeyed M Hosseini-Moghaddam, Bin Luo, Sarah E Bota, et al.
Plos One|August 10, 2019
A controlled-release oral opioid supports S. aureus survival in injection drug preparation equipment and may increase bacteremia and endocarditis riskKatherine J Kasper, Iswarya Manoharan, Brian Hallam, et al.
Clinical Transplantation|March 13, 2021
Late-onset allograft rejection, cytomegalovirus infection, and renal allograft loss: Is anti-CMV prophylaxis required following late-onset allograft rejection?Mohammadreza Rahimishahmirzadi, Anthony M Jevnikar, Andrew A House, et al.
Plos One|September 20, 2019
Correction: A controlled-release oral opioid supports S. aureus survival in injection drug preparation equipment and may increase bacteremia and endocarditis riskKatherine J Kasper, Iswarya Manoharan, Brian Hallam, et al.
Plos Neglected Tropical Diseases|February 1, 2008
On the origin of the treponematoses: a phylogenetic approachKristin N Harper, Paolo S Ocampo, Bret M Steiner, et al.
Cancer Immunology, Immunotherapy : CII|November 17, 2022
Improved MAIT cell functions following fecal microbiota transplantation for metastatic renal cell carcinomaMarina Ninkov, Crystal L Schmerk, Manoosh Moradizadeh, et al.
JAMA Network Open|August 2, 2022
Association of Higher-Dose Fluoroquinolone Therapy With Serious Adverse Events in Older Adults With Advanced Chronic Kidney DiseaseFlory Tsobo Muanda, Manish M Sood, Matthew A Weir, et al.
Trends in Molecular Medicine|January 9, 2024
Dissecting mechanisms of fecal microbiota transplantation efficacy in diseaseCatherine M Andary, Kait F Al, John A Chmiel, et al.
Pageof 4

Showing results (11-20 of 37) with videos related to

Sort By:
Pageof 4
Transplant Infectious Disease : an Official Journal of the Transplantation Society|May 29, 2023
The effect of late-onset CMV infection on the outcome of renal allograft considering initial graft functionMohammadreza R Shahmirzadi, Lakshman Gunaratnam, Anthony M Jevnikar, et al.
Frontiers in Medicine|August 28, 2020
Treating From the Inside Out: Relevance of Fecal Microbiota Transplantation to Counteract Gut Damage in GVHD and HIV InfectionJing Ouyang, Stéphane Isnard, John Lin, et al.
JAMA Network Open|December 29, 2021
Incidence and Outcomes Associated With Clostridioides difficile Infection in Solid Organ Transplant RecipientsSeyed M Hosseini-Moghaddam, Bin Luo, Sarah E Bota, et al.
Plos One|August 10, 2019
A controlled-release oral opioid supports S. aureus survival in injection drug preparation equipment and may increase bacteremia and endocarditis riskKatherine J Kasper, Iswarya Manoharan, Brian Hallam, et al.
Clinical Transplantation|March 13, 2021
Late-onset allograft rejection, cytomegalovirus infection, and renal allograft loss: Is anti-CMV prophylaxis required following late-onset allograft rejection?Mohammadreza Rahimishahmirzadi, Anthony M Jevnikar, Andrew A House, et al.
Plos One|September 20, 2019
Correction: A controlled-release oral opioid supports S. aureus survival in injection drug preparation equipment and may increase bacteremia and endocarditis riskKatherine J Kasper, Iswarya Manoharan, Brian Hallam, et al.
Plos Neglected Tropical Diseases|February 1, 2008
On the origin of the treponematoses: a phylogenetic approachKristin N Harper, Paolo S Ocampo, Bret M Steiner, et al.
Cancer Immunology, Immunotherapy : CII|November 17, 2022
Improved MAIT cell functions following fecal microbiota transplantation for metastatic renal cell carcinomaMarina Ninkov, Crystal L Schmerk, Manoosh Moradizadeh, et al.
JAMA Network Open|August 2, 2022
Association of Higher-Dose Fluoroquinolone Therapy With Serious Adverse Events in Older Adults With Advanced Chronic Kidney DiseaseFlory Tsobo Muanda, Manish M Sood, Matthew A Weir, et al.
Trends in Molecular Medicine|January 9, 2024
Dissecting mechanisms of fecal microbiota transplantation efficacy in diseaseCatherine M Andary, Kait F Al, John A Chmiel, et al.
Pageof 4